A Study of HL40626S Tablets in Healthy Adults

NCT07736586 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis (PsO)
Skin Disease
Immune System Disease
Skin Diseases, Papulosquamous

Interventions

DRUG: HL40626S tablets
DRUG: HL40626S placebo

Sponsor

HighsLab Therapeutics Inc.